Clinical Trial Update: GD-11 for Injection in the Treatment of Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for GD-11 injection in acute ischemic stroke; status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• GD-11

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: UNKNOWN